» Articles » PMID: 36577524

Two Mutations in the Gene Reveal a Diagnosis of Shwachman-Diamond Syndrome in a Patient with Atypical Symptoms

Overview
Specialty Genetics
Date 2022 Dec 28
PMID 36577524
Authors
Affiliations
Soon will be listed here.
Abstract

We present the case of a 53-yr-old woman with an inherited bone marrow failure coexisting with uncommon extrahematological symptoms, such as cirrhosis and skin abnormalities. Whole-exome sequencing revealed a diagnosis of Shwachman-Diamond syndrome (SDS) with an atypical presentation. Unexpected was the age of disease expression, normally around the pediatric age, with a predominantly median survival age of 36 yr. To our knowledge, she was the first adult patient with a molecular diagnosis of Shwachman-Diamond in Uruguay. The patient was referred to our service when she was 43-yr-old with a history of bone marrow failure with anemia and thrombocytopenia. All secondary causes of pancytopenia were excluded. Bone marrow aspirate and biopsy specimens were hypocellular for the patient's age. Numerous dysplastic features were observed in the three lineages. She had a normal karyotype and normal chromosomal fragility. A diagnosis of low-risk hypoplastic MDS was made. Dermatological examination revealed reticulate skin pigmentation with hypopigmented macules involving the face, neck, and extremities; nail dystrophy; premature graying; and thin hair. Extrahematological manifestations were present (e.g., learning difficulties, short stature). Last, she was diagnosed with cryptogenic liver cirrhosis CHILD C. This rules out all other possible causes of chronic liver disease. This clinical presentation initially oriented the diagnosis toward telomeropathy, so we did a telomeropathy NGS panel that came up negative. Finally, we did an exome sequencing that confirmed the diagnosis of SDS. Using whole-exome sequencing, we were able to find two compound heterozygous mutations in the gene that were responsible for the phenotype of a patient that was undiagnosed for 10 years. An earlier genetic diagnosis could have influenced our patient's outcome.

References
1.
Donadieu J, Fenneteau O, Beaupain B, Beaufils S, Bellanger F, Mahlaoui N . Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica. 2012; 97(9):1312-9. PMC: 3436231. DOI: 10.3324/haematol.2011.057489. View

2.
Palmer E, Sachdev R, Macintosh R, Melo U, Mundlos S, Righetti S . Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies. Neurology. 2021; 96(13):e1770-e1782. DOI: 10.1212/WNL.0000000000011655. View

3.
Hall G, Dale P, Dodge J . Shwachman-Diamond syndrome: UK perspective. Arch Dis Child. 2006; 91(6):521-4. PMC: 2082808. DOI: 10.1136/adc.2003.046151. View

4.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

5.
Trujillano D, Bertoli-Avella A, Kandaswamy K, Weiss M, Koster J, Marais A . Clinical exome sequencing: results from 2819 samples reflecting 1000 families. Eur J Hum Genet. 2016; 25(2):176-182. PMC: 5255946. DOI: 10.1038/ejhg.2016.146. View